MARKET

LQDA

LQDA

Liquidia Corporation
NASDAQ
15.32
+0.45
+3.03%
Opening 13:23 03/27 EDT
OPEN
14.87
PREV CLOSE
14.87
HIGH
15.49
LOW
14.84
VOLUME
223.74K
TURNOVER
--
52 WEEK HIGH
16.92
52 WEEK LOW
8.26
MARKET CAP
1.31B
P/E (TTM)
-9.2473
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LQDA last week (0317-0321)?
Weekly Report · 3d ago
Liquidia Technologies’ Earnings Call: Mixed Sentiments and Strategic Growth
TipRanks · 5d ago
What 4 Analyst Ratings Have To Say About Liquidia
Benzinga · 6d ago
Liquidia Is Maintained at Sector Outperform by Scotiabank
Dow Jones · 03/20 15:52
Scotiabank Maintains Sector Outperform on Liquidia, Raises Price Target to $34
Benzinga · 03/20 15:43
Tesla To $450? Here Are 10 Top Analyst Forecasts For Thursday
Benzinga · 03/20 12:15
Liquidia Price Target Maintained With a $29.00/Share by HC Wainwright & Co.
Dow Jones · 03/20 10:40
HC Wainwright & Co. Reiterates Buy on Liquidia, Maintains $29 Price Target
Benzinga · 03/20 10:30
More
About LQDA
Liquidia Corporation is a biopharmaceutical company. The Company is focused on the development, manufacture and commercialization of products that address unmet patient needs, with a focus directed towards rare cardiopulmonary diseases, such as pulmonaryarterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The Company operates through its wholly owned operating subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. Its proprietary PRINT technology is a particle engineering platform, which enable precise production of uniform drug particles. Its lead product candidate is YUTREPIA for the treatment of PAH and PH-ILD. YUTREPIA is an inhaled dry powder formulation of treprostinil designed with PRINT to improve the therapeutic profile of treprostinil by enhancing deep lung delivery while using a convenient, dry-powder inhaler (DPI) and by achieving higher dose levels than the labeled doses of current inhaled therapies.

Webull offers Liquidia Corp stock information, including NASDAQ: LQDA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LQDA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LQDA stock methods without spending real money on the virtual paper trading platform.